SCHEMBL14973138

SCHEMBL14973138

Cn1ncc(C(=O)NNC(=O)c2cccc(S(N)(=O)=O)c2)c1COc1ccc(F)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.37
MAOA P21397 1/20 0.37
CXCR2 P25025 2/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PKM P14618 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CA2 P00918 3/20 0.36
BRAF P15056 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
STAT3 P40763 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA6 P23280 2/20 0.35
CA7 P43166 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973000 0.89 MRGPRX4 (0.45) CA2MAPTHTTCA12CA1
SCHEMBL14973083 0.85 L3MBTL1 (0.39) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL14973349 0.82 MAPT (0.44) MAPTHTTPOLB
SCHEMBL14973167 0.79 ADAMTS4 (0.42) MAOALMNACA2MAPTCA12
SCHEMBL14937608 0.76 CA12 (0.46) MEN1KMT2ACA2CA12CA1
SCHEMBL14973113 0.75 PTGS2 (0.41) MEN1KMT2ACA2MAPTCA12
SCHEMBL14972927 0.74 GRM5 (0.38) MAOA
SCHEMBL14973276 0.73 CA9 (0.46) MAOACA2CA12CA1CA9
SCHEMBL14973206 0.73 CA4 (0.49) MAOACA2CA12CA1CA9
SCHEMBL14973325 0.73 MAOB (0.53) MAOANPC1RAB9ACA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A SIRT2 3695/4885MAOA 1641/4885CXCR2 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.